Wenbo Guo

Wenbo Guo

Auto-generated profile, based on publicly available information

Wenbo Guo

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2023 in Journal of Genetics and Genomics
Verified
Journal Article
Closed access
WGWenbo Guo
Wenbo Guo
YHYining Hu
Yining Hu
JQJingyang Qian
Jingyang Qian
LZLidan Zhu
Lidan Zhu
JCJunyun Cheng
Junyun Cheng
XFXiaohui Fan
Xiaohui Fan

11 December 2022 in Advanced Science
Verified
Journal Article
Open access
JCJunyun Cheng
Junyun Cheng
GLGaole Lin
Gaole Lin
TWTianhao Wang
Tianhao Wang
YWYunzhu Wang
Yunzhu Wang
WGWenbo Guo
Wenbo Guo
XFXiaohui Fan
Xiaohui Fan
The clustered regularly interspaced short palindromic repeats (CRISPR)‐based genetic screening has been demonstrated as a powerful approach for unbiased functional genomics research. Single‐cell CRISPR screening (scCRISPR) techniques, which result from the combination of single‐cell toolkits and CRISPR screening, allow dissecting regulatory networks in complex biological systems at unprecedented resolution. These methods allow cells to be perturbed en masse using a pooled CRISPR library, followed by high‐content phenotyping. This is technically accomplished by annotating cells with sgRNA‐specific barcodes or directly detectable sgRNAs. According to the integration of distinct single‐cell technologies, these methods principally fall into four categories: scCRISPR with RNA‐seq, scCRISPR with ATAC‐seq, scCRISPR with proteome probing, and imaging‐based scCRISPR. scCRISPR has deciphered genotype–phenotype relationships, genetic regulations, tumor biological issues, and neuropathological mechanisms. This review provides insight into the technical breakthrough of scCRISPR by systematically summarizing the advancements of various scCRISPR methodologies and analyzing their merits and limitations. In addition, an application‐oriented approach guide is offered to meet researchers’ individualized demands.

12 April 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
Lei LiLei Li
Lei Li
HCHerong Cui
Herong Cui
YZYue Zhang
Yue Zhang
WXWei Xie
Wei Xie
YLYing Lin
Ying Lin
CWCheng-Xiang Wang
Cheng-Xiang Wang
Multidrug-resistance (MDR) Pseudomonas aeruginosa (P. aeruginosa) is a lethal gram-negative pathogen causing hospital-acquired and ventilator-associated pneumonia, which is difficult to treat. Our previous studies confirmed that baicalin, an essential bioactive component in Scutellaria baicalensis Georgi, exhibited anti-inflammatory effects in an acute pneumonia rat model induced by MDR P. aeruginosa. However, this effect of baicalin in constrast its low bioavailability, and its mechanism of action is still unknown. Thus, this study investigated whether the therapeutic effects of baicalin against MDR P. aeruginosa acute pneumonia are owing to the regulation of gut microbiota and their metabolites using pyrosequencing of the 16S rRNA genes in rat feces and metabolomics. As a result, baicalin attenuated the inflammation by acting directly on neutrophils and regulated the production of the inflammatory cytokines TNF-α, IL-1β, IL-6, and IL-10. The mechanisms were through down-regulation of TLR4 and inhibition of NF-κB. Furthermore, pyrosequencing of the 16S rRNA genes in rat feces revealed that baicalin regulated the composition of gut microbial communities. At the genus level, baicalin efficiently increased the abundance of Ligilactobacillus, Lactobacillus and Bacteroides, but decreased the abundance of Muribaculaceae and Alistipes. Further, arginine biosynthesis was analyzed as the core pathway regulated by baicalin via combination with predicting gut microbiota function and targeted metabolomics. In conclusion, this study has demonstrated that baicalin relieved inflammatory injury in acute pneumonia rat induced by MDR P. aeruginosa via arginine biosynthesis associated with gut microbiota. Baicalin could be a promising and effective adjunctive therapy for lung inflammation caused by MDR P. aeruginosa infection.

1 January 2025 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
GCGuoqian Cui
Guoqian Cui
MLMuzi Li
Muzi Li
WGWenbo Guo
Wenbo Guo
MGMeng Gao
Meng Gao
QZQin Zhu
Qin Zhu
LLLiao Liao
Liao Liao
Traditional Medicine (TM), especially Traditional Chinese Medicine (TCM), is renowned for its distinctive "multi-component-multi-target-multi-pathway" mode of action, which exhibits a unique overall regulatory therapeutic effect. However, the intricate nature of TCM poses significant challenges in identifying active components, elucidating mechanisms of action, and standardizing clinical practices. The advancement of modern science and technology has led to the gradual modernization of TCM research. Network pharmacology (NP) has emerged as a pivotal framework for comprehending the holistic mechanisms of TCM, offering a crucial avenue for unveiling intricate biological networks by integrating chemical information, omics data, and clinical efficacy evidence. Nevertheless, conventional NP approaches exhibit notable limitations, including substantial noise, high dimensionality, challenges in capturing dynamics and time series, and inadequate cross-scale integration, thereby constraining their utility in precise mechanism analysis and clinical translation. In recent years, artificial intelligence (AI), particularly machine learning (ML), deep learning (DL), and graph neural networks (GNN), have empowered NP in an unprecedented way, enabling it to systematically and accurately analyze the cross-scale mechanisms of TCM from molecular interactions to patient efficacy. This review will systematically examine the latest developments in artificial intelligence-network pharmacology (AI-NP) methodology, with a focus on typical research cases of multi-scale mechanism analysis at the molecular, cellular, tissue, and patient levels. It will systematically summarize the challenges currently faced and explore future development directions to fully unlock the systemic therapeutic wisdom of TCM.

18 July 2025 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
GCGuoqian Cui
Guoqian Cui
WGWenbo Guo
Wenbo Guo
MLMuzi Li
Muzi Li
SCShengshuang Chen
Shengshuang Chen
XSXin Shao
Xin Shao
XFXiaohui Fan
Xiaohui Fan
Introduction: Cerebral ischemia (CI) is a severe neurological disorder characterized by high incidence and disability rates. Its pathogenesis is complex, involving multiple interrelated biological processes. Among these, intercellular communication has emerged as a key mechanism regulating the damage and recovery phases of CI. It controls information exchange between cells, thereby playing a crucial role in cellular responses to ischemic injury. Understanding how intercellular communication promotes the pathophysiology of CI may provide valuable insights into new therapeutic targets. Methods: To elucidate the role of intercellular communication in CI, recent literature was analyzed, with a focus on how intercellular communication influences cellular behaviors and metabolism. This review integrates data from molecular biology, cellular signaling studies, and cerebral ischemia models. Results: Studies indicate that intercellular communication significantly influences the progression and outcomes of CI. Intercellular communication not only participates in regulating the inflammatory response following injury but also plays a dual role in neuroprotection and regeneration. Discussion: The dual role of intercellular communication—exacerbating damage through inflammatory cascades and promoting recovery through neuroprotective mechanisms—highlights its complex contribution to the pathology of CI. Cellular crosstalk between neurons, glial cells, endothelial cells, and immune cells coordinates the dynamic response to ischemic injury. Understanding these dynamics offers promising opportunities for targeted interventions. Conclusion: Intercellular communication plays a central role in the mechanisms of injury and repair in cerebral ischemia. By influencing inflammation, neuroprotection, and regeneration, it serves as both a mediator of injury and a potential therapeutic target. Further research is needed to fully elucidate these mechanisms and translate them into effective clinical strategies for treating CI.

1 September 2010 in Zeitschrift für Kristallographie - New Crystal Structures
Verified
Journal Article
Open access
WGWen-Bo Guo
Wen-Bo Guo
PHPu-Zhou Hu
Pu-Zhou Hu
SMShao-Bin Miao
Shao-Bin Miao
BZBang-Tun Zhao
Bang-Tun Zhao